Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

Cited In for PubMed (Select 21037086)

1.

The role of radiotherapy in Hodgkin's lymphoma: what has been achieved during the last 50 years?

Witkowska M, Majchrzak A, Smolewski P.

Biomed Res Int. 2015;2015:485071. doi: 10.1155/2015/485071. Epub 2015 Feb 1. Review.

2.

Identifying and addressing the needs of adolescents and young adults with cancer: summary of an Institute of Medicine workshop.

Nass SJ, Beaupin LK, Demark-Wahnefried W, Fasciano K, Ganz PA, Hayes-Lattin B, Hudson MM, Nevidjon B, Oeffinger KC, Rechis R, Richardson LC, Seibel NL, Smith AW.

Oncologist. 2015 Feb;20(2):186-95. doi: 10.1634/theoncologist.2014-0265. Epub 2015 Jan 7. Review.

PMID:
25568146
3.

Conditional survival in pediatric malignancies: Analysis of data from the Childhood Cancer Survivor Study and the Surveillance, Epidemiology, and End Results Program.

Mertens AC, Yong J, Dietz AC, Kreiter E, Yasui Y, Bleyer A, Armstrong GT, Robison LL, Wasilewski-Masker K.

Cancer. 2015 Apr 1;121(7):1108-17. doi: 10.1002/cncr.29170. Epub 2014 Dec 29.

PMID:
25557134
4.

Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?

Dunleavy K, Wilson WH.

Blood. 2015 Jan 1;125(1):33-9. doi: 10.1182/blood-2014-05-575092. Epub 2014 Dec 11. Review.

PMID:
25499450
5.

Pediatric lymphomas and histiocytic disorders of childhood.

Allen CE, Kelly KM, Bollard CM.

Pediatr Clin North Am. 2015 Feb;62(1):139-65. doi: 10.1016/j.pcl.2014.09.010. Review.

PMID:
25435117
6.

The Initiative to Maximize Progress in Adolescent and Young Adult Cancer Therapy (IMPACT) Cohort Study: a population-based cohort of young Canadians with cancer.

Baxter NN, Daly C, Gupta S, Pole JD, Sutradhar R, Greenberg ML, Nathan PC.

BMC Cancer. 2014 Nov 3;14:805. doi: 10.1186/1471-2407-14-805.

7.

Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031.

Friedman DL, Chen L, Wolden S, Buxton A, McCarten K, FitzGerald TJ, Kessel S, De Alarcon PA, Chen AR, Kobrinsky N, Ehrlich P, Hutchison RE, Constine LS, Schwartz CL.

J Clin Oncol. 2014 Nov 10;32(32):3651-8. doi: 10.1200/JCO.2013.52.5410. Epub 2014 Oct 13.

PMID:
25311218
8.

Small molecule growth inhibitors of human oncogenic gammaherpesvirus infected B-cells.

Dzeng RK, Jha HC, Lu J, Saha A, Banerjee S, Robertson ES.

Mol Oncol. 2015 Feb;9(2):365-76. doi: 10.1016/j.molonc.2014.09.006. Epub 2014 Sep 26.

PMID:
25306391
9.

Use of appropriate initial treatment among adolescents and young adults with cancer.

Potosky AL, Harlan LC, Albritton K, Cress RD, Friedman DL, Hamilton AS, Kato I, Keegan TH, Keel G, Schwartz SM, Seibel NL, Shnorhavorian M, West MM, Wu XC; AYA HOPE Study Collaborative Group.

J Natl Cancer Inst. 2014 Oct 9;106(11). pii: dju300. doi: 10.1093/jnci/dju300. Print 2014 Nov.

PMID:
25301964
10.

Coronary artery disease detected by coronary computed tomography angiography in adult survivors of childhood Hodgkin lymphoma.

Mulrooney DA, Nunnery SE, Armstrong GT, Ness KK, Srivastava D, Donovan FD, Kurt BA, Metzger ML, Krasin MJ, Joshi V, Durand JB, Robison LL, Hudson MM, Flamm SD.

Cancer. 2014 Nov 15;120(22):3536-44. doi: 10.1002/cncr.28925. Epub 2014 Jul 16.

PMID:
25041978
11.

Causes of death in long-term survivors of head and neck cancer.

Baxi SS, Pinheiro LC, Patil SM, Pfister DG, Oeffinger KC, Elkin EB.

Cancer. 2014 May 15;120(10):1507-13. doi: 10.1002/cncr.28588. Epub 2014 Feb 22.

PMID:
24863390
12.

Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer.

Sanoff HK, Deal AM, Krishnamurthy J, Torrice C, Dillon P, Sorrentino J, Ibrahim JG, Jolly TA, Williams G, Carey LA, Drobish A, Gordon BB, Alston S, Hurria A, Kleinhans K, Rudolph KL, Sharpless NE, Muss HB.

J Natl Cancer Inst. 2014 Apr;106(4):dju057. doi: 10.1093/jnci/dju057. Epub 2014 Mar 28.

13.
14.

Potential increased risk of ischemic heart disease mortality with significant dose fractionation in the Canadian Fluoroscopy Cohort Study.

Zablotska LB, Little MP, Cornett RJ.

Am J Epidemiol. 2014 Jan 1;179(1):120-31. doi: 10.1093/aje/kwt244. Epub 2013 Oct 20.

15.

Systemic cancer therapy: achievements and challenges that lie ahead.

Palumbo MO, Kavan P, Miller WH Jr, Panasci L, Assouline S, Johnson N, Cohen V, Patenaude F, Pollak M, Jagoe RT, Batist G.

Front Pharmacol. 2013 May 7;4:57. doi: 10.3389/fphar.2013.00057. eCollection 2013.

16.

Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease.

Antoni D, Natarajan-Ame S, Meyer P, Niederst C, Bourahla K, Noel G.

Radiat Oncol. 2013 May 2;8:112. doi: 10.1186/1748-717X-8-112.

17.

Using biologic predictive factors to direct therapy of diffuse large B-cell lymphoma.

Dunleavy K, Grant C, Wilson WH.

Ther Adv Hematol. 2013 Feb;4(1):43-57. doi: 10.1177/2040620712464508.

18.

Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk.

Braunstein S, Nakamura JL.

Front Oncol. 2013 Apr 3;3:73. doi: 10.3389/fonc.2013.00073. eCollection 2013.

19.

Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance.

Carver JR, Szalda D, Ky B.

Semin Oncol. 2013 Apr;40(2):229-38. doi: 10.1053/j.seminoncol.2013.01.005.

20.

Development of a comprehensive health-related needs assessment for adult survivors of childhood cancer.

Cox CL, Sherrill-Mittleman DA, Riley BB, Hudson MM, Williams LJ, Leisenring WM, Zacher MG, Robison LL.

J Cancer Surviv. 2013 Mar;7(1):1-19. doi: 10.1007/s11764-012-0249-3. Epub 2012 Dec 5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk